Cohort Company News - MedTech Innovator

PharmaJet and Abnova partner to develop and deliver COVID-19 mRNA Vaccine using Needle-free Injection technology

DateMay 19 2020

PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its Needle-free Injection System technology will be used to deliver a messenger RNA (mRNA) vaccine against SARS-CoV-2. The vaccine is being developed by Abnova Corporation, the world's largest antibody manufacturer, based in Taiwan.

PyrAmes Is Granted Breakthrough Device Designation for Boppli, a Continuous, Non-Invasive Blood Pressure Monitoring System

DateMay 18 2020

Breakthrough Device Designation has the potential to accelerate our plans to bring Boppli to market to improve medical care for babies in need of better blood pressure monitoring.

Houston’s Allotrope Medical wins 2020 Texas A&M New Ventures Competition

DateMay 14 2020

Dr. Albert Huang’s company Allotrope Medical took home the top $50,000 prize for the StimSite technology, which is a smooth muscle stimulation technology that allows surgeons to rapidly and safely identify critical tissue structures, like the ureter, during surgery.

Day Zero Diagnostics wins $6.2m from accelerator

DateMay 12 2020

Boston-based Day Zero said in a news release that its system helps offer the most effective antibiotic treatment on the first day that patients are admitted to the hospital, rather than having them undergo multiple days of toxic broad-spectrum antibiotics to prevent septic shock.

Genetesis lands strategic investment to close $9.2M Series B

DateMay 08 2020

Genetesis Inc, a medical technology company that has developed non-invasive, biomagnetic CardioFluxTM imaging, today announced several important updates. The company has closed significant strategic investments from TDK Ventures and an undisclosed Fortune 500 global, healthcare company, completing a $9.2M Series B financing. The round included participation by return investors CincyTech, Ohio Innovation Fund and Mark Cuban.

Antibody testing for COVID-19 prepares for its closeup in bid to ease pandemic restrictions

DateMay 07 2020

San Diego-based Abreos Biosciences Inc. is looking to create a multiplex test that goes beyond the simple yes/no COVID-19 antibody results and measures the “specific flavors” of antibodies to provide a more complete picture of the antibodies in a person’s blood.

Louisville medical device company gets emergency FDA approval

DateMay 05 2020

Louisville-based Liberate Medical LLC received an emergency use authorization from the Food and Drug Administration to market its core product, VentFree, during the coronavirus crisis, Louisville Business First reports. VentFree aims to prevent breathing muscles from degrading while patients are on a ventilator.

Medable Secures $25M Funding To Reduce Clinical Trial Timelines

DateMay 04 2020

“The continued participation in clinical trials is important right now,” Medable co-founder and CEO Michelle Longmire, M.D., told Crunchbase News. “Prior to COVID, decentralized clinical trials were a novel, innovative approach. Now that clinics are shut down, decentralized clinical trials are the only approach to continued clinical trials, especially for finding a COVID vaccine. We are the only tech company to be able to provide this service, and we had to make sure we had the capital to execute this platform.”

Onkos Surgical raises $7.6m

DateApr 30 2020

Surgical oncology device developer Onkos Surgical filed an SEC Form D to confirm the sale of nearly $7.6 million in equity. Earlier this year, the company announced the launch of its GenVie Magnesium Bone Scaffold. The magnesium-based bone void filler with osteoconductive and high compression strength attributes to promote bone repair and regeneration.

Baxter Reports First-Quarter 2020 Results

DateApr 30 2020

Acquired toSense, a California-based technology company focused on developing sensors and software for broad applications in non-invasive patient monitoring. toSense brings technology and expertise that is expected to be instrumental in Baxter’s development and launch of leading-edge monitoring innovations.

AtaCor Medical completes $25m Series B

DateApr 28 2020

AtaCor said in a news release that the investment is earmarked for efforts to garner U.S. and European regulatory clearances for its novel extracardiac temporary pacing system, while it may also be used to fund development efforts for additional extracardiac therapies.

TDK Ventures Invests in Biomagnetic Medical Imaging Company Genetesis

DateApr 21 2020

“TDK’s rich history in magnetics and its recent breakthroughs in biomagnetics at picoTesla levels makes them one of our strongest partners to date,” said Peeyush Shrivastava, CEO and founder of Genetesis. “We are committed to bring the most accurate diagnostics that can assist emergency physicians and cardiologists in making the best decisions for cardiac health in a non-invasive and rapid fashion. We are elated to have TDK as our strategic partner because of their pioneering work in magnetic materials and its commercialization. Their recent leadership around supporting frontier-tech entrepreneurs caught our attention and we are excited about this next chapter.”

Companies Launch New Framework to Accelerate COVID-19 Research; Streamlines Path for Diagnostics, Monitoring and Clinical Trials

DateApr 20 2020

Medable Inc. today announced a multi-company research framework to accelerate development of diagnostics and treatments for COVID-19, providing individuals fast access to participate in leading-edge research for diagnostics, health monitoring and interventional clinical trials. The ACCESS initiative-short for American COVID-19 Collaborative Enabling Seamless Science-provides a mobile consumer application and secure infrastructure to quickly connect health researchers and clinical trial teams securely with up to millions of home-bound individuals in the United States.

This physician-founder is making a device to protect medical staff during intubation procedures

DateApr 16 2020

Dr. Steven Tropello is bringing experience and a network developed while building local startup CoapTech. Working as an emergency and critical care physician at the University of Maryland School of Medicine, Dr. Steven Tropello is seeing the lack of protective equipment for medical workers up close. With emails from colleagues going to Lowe’s hardware store to find supplies, Dr. Tropello was resolved to create a better solution. As a cofounder of Baltimore-based startup CoapTech, he also had previous experience developing a medical device to draw on.

Gauss Partners with Evive to Launch Mobile App for COVID-19 Testing and Research

DateApr 16 2020

Gauss, a leading developer of digital decision-support tools for the medical frontlines, in partnership with Evive, the leader in enterprise communications and benefits engagement, has today announced the nationwide release of Apollo, a free Apple iOS app and WebApp, to help increase safety and efficiency of drive-through COVID-19 screening and testing for patients and health workers. The app will also facilitate Stanford Medicine’s Apollo COVID-19 Screening Survey (Apollo Study). Apollo helps people determine if they are likely to qualify for COVID-19 testing based on CDC guidelines and helps them find a nearby testing facility from a nationwide directory.

Hillel’s Tech Corner: Clues to the COVID-19 crisis

DateApr 10 2020

CLEW Medical are literally navigating the maze of patient data providing clues where they are most needed and where there would otherwise be none.

Carnation Ambulatory Monitor patch used to detect arrhythmias in COVID-19 patients

DateApr 09 2020

Bardy Diagnostics has announced that its Carnation Ambulatory Monitor (CAM) Patch has been chosen for use in protocols to measure QT Segments in COVID-19 patients who have been prescribed hydroxychloroquine (HCQ). BardyDx’s CAM Patch will be utilised in newly established protocols at hospitals across the Seattle area to monitor cardiac rhythms for COVID-19 patients on HCQ after hospital discharge, as well as for outpatients.

SilverCloud Health Raises $16M in Series B Funding

DateApr 08 2020

The company intends to use the funds to further expand program offerings in North America, enhance the current global portfolio, and conduct additional research and clinical trials. The company’s mental health programs are currently used globally by more than 300 organizations and by more than 350,000 users.

Nanomix Awarded BARDA Contract for Development of Rapid, Mobile, Point-of-Care Assays to Detect COVID-19 Infection

DateApr 08 2020

Nanomix, a leader in the development of mobile, affordable, point-of-care diagnostics, today announced that the company has been awarded up to approximately $570,000 in funding from Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. These funds support development and testing of COVID-19 point-of-care tests that will run on the Nanomix eLab analyzer, which provides results in less than 15 minutes.

Spire Health Helps Pulmonary, Critical Care & Sleep Disorders Institute of South Florida Remotely Monitor High Risk Patients in Fight Against Coronavirus

DateApr 02 2020

Spire Health, the leading digital healthcare company for continuous respiratory remote patient monitoring, and PCSI, a large outpatient pulmonary group in the Palm Beach area of Florida, announced today a collaborative partnership to remotely monitor chronic respiratory disease patients from home in an effort to help PCSI healthcare providers detect early signs of COVID-19 and limit exposure for healthy patients.